Ajna Biosciences

#Ajna Biosciences #Autism #Neuroscience

The promise of a botanical approach to autism

DDW Editor Reece Armstrong speaks to Joel Stanley, CEO of Ajna BioSciences, about the challenges of developing therapies for autism and why a multi-compound approach may be key to treating symptoms.  RA: What are the challenges of discovering and developing effective therapies for autism?   JS: Autism is an incredibly broad spectrum, which makes it fundamentally different from… Read More

#Exclusive Content

#Ajna Biosciences #Botanical #Drug development #Plant-based #Therapeutics

New podcast: Redefining the future with plant-based therapeutics

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Joel Stanley, CEO… Read More

#News